Table 2: Effect of Chy on day 4 ELT and day 5 time spent in target quadrant (TSTQ) of mice using MWM.

GroupTreatmentDoseDay 1 ELT (s)Day 4 ELT (s)Day 5 TSTQ (s)

IControl (normal)Standard diet69.7 ± 2.425.6 ± 1.8a73.4 ± 3.6
IIChy1% w/w, in diet68.6 ± 1.624.2 ± 2.470.6 ± 4.2
IIIChy2% w/w, in diet65.6 ± 0.626.7 ± 2.972.8 ± 2.4
IVPiracetam400 mg kg−1; i.p.67.9 ± 3.913.4 ± 3.1b89.9 ± 2.2e
VSco1.4 mg kg−1; i.p.66.3 ± 3.556.2 ± 3.6b29.2 ± 4.9e
VIChy + Sco1% w/w, in diet + 1.4 mg kg−1; i.p.64.3 ± 1.234.8 ± 2.1c52.1 ± 1.8f
VIIChy + Sco2% w/w, in diet + 1.4 mg kg−1; i.p.62.1 ± 4.325.4 ± 1.3c61.2 ± 4.6f
VIIIPiracetam + Sco400 mg kg−1; i.p. + 1.4 mg kg−1; i.p.62.3 ± 2.914.4 ± 2.7c66.3 ± 2.8f
IXAlp0.5 mg kg−1; i.p.63.4 ± 2.959.9 ± 4.3b24.3 ± 1.2e
XChy + Alp1% w/w, in diet + 0.5 mg kg−1; i.p.63.7 ± 2.732.1 ± 1.6d54.2 ± 3.2g
XIChy + Alp2% w/w, in diet + 0.5 mg kg−1; i.p.60.1 ± 2.522.1 ± 4.1d64.6 ± 3.7g
XIIPiracetam + Alp400 mg kg−1; i.p. + 0.5 mg kg−1; i.p.66.3 ± 1.917.3 ± 2.3d69.1 ± 3.6g

Piracetam (400 mg kg−1; i.p.) is used as a standard drug. Values are mean ± SEM.
aP < .05 as compared to day 1 ELT in control.
bP < .05 as compared to day 4 ELT in control.
cP < .05 as compared with day 4 ELT in Sco group.
dP < .05 as compared with day 4 ELT in Alp group.
eP < .05 as compared to day 5 TSTQ in control.
fP < .05 as compared with day 5 TSTQ in Sco group.
gP < .05 as compared with day 5 TSTQ in Alp group.